Jan Gerard Maring
Department of Pharmacy
Diaconessen Hospital
Meppel and Bethesda Hospital
Hoogeveen
Netherlands
Name/email consistency: high
- A simple and sensitive fully validated HPLC-UV method for the determination of 5-fluorouracil and its metabolite 5,6-dihydrofluorouracil in plasma. Maring, J.G., Schouten, L., Greijdanus, B., de Vries, E.G., Uges, D.R. Ther. Drug. Monit (2005)
- Genetic factors influencing pyrimidine-antagonist chemotherapy. Maring, J.G., Groen, H.J., Wachters, F.M., Uges, D.R., de Vries, E.G. Pharmacogenomics J. (2005)
- Extensive hepatic replacement due to liver metastases has no effect on 5-fluorouracil pharmacokinetics. Maring, J.G., Piersma, H., van Dalen, A., Groen, H.J., Uges, D.R., De Vries, E.G. Cancer Chemother. Pharmacol. (2003)
- Reduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene. Maring, J.G., van Kuilenburg, A.B., Haasjes, J., Piersma, H., Groen, H.J., Uges, D.R., Van Gennip, A.H., De Vries, E.G. Br. J. Cancer (2002)
